Clinic-based cases with frontotemporal dementia show increased cerebrospinal fluid tau and high apolipoprotein E ε4 frequency, but no tau gene mutations

Experimental Neurology

Volumn 168, Issue 2, 2001, Pages 413-418

  Froelich Fabre, Susanne ^a   Forsell, Charlotte ^a   Viitanen, Matti ^a   Sjögren, Magnus ^b   Wallin, Anders ^b   Blennow, Kaj ^b,c   Blomberg, Marie ^a   Andersen, Christian ^a   Wahlund, Lars Olof ^a   Lannfelt, Lars ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^c Swedish Medical Research Council   (Sweden)

Author keywords

Apolipoprotein E; Cerebrospinal fluid; Frontotemporal dementia; Polymorphisms; Tau

Indexed keywords

APOLIPOPROTEIN E; TAU PROTEIN;

ADULT; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; FAMILY HISTORY; FEMALE; FRONTOTEMPORAL DEMENTIA; GENE FREQUENCY; GENE MUTATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN CEREBROSPINAL FLUID LEVEL;

EID: 0035072923     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.2000.7613     Document Type: Article

References (45)

1. Cerebrospinal fluid tau protein as a biochemical marker for Alzheimer's disease: A community based follow up study
2. Cerebrospinal fluid tau levels in neurodegenerative diseases with distinct tau-related pathology
3. Association of an extended haplotype in the tau gene with progressive supranuclear palsy
4. Biological markers for the diagnosis of Alzheimer's disease
5. Direct genetic evidence for involvement of tau in progressive supranuclear palsy: European Study Group on Atypical Parkinsonism Consortium
6. Tau protein in cerebrospinal fluid: A biochemical marker for axonal degeneration in Alzheimer disease?
7. Clinical and neuropathological criteria for frontotemporal dementia
8. Comparative biochemistry of tau in progressive supranuclear palsy, corticobasal degeneration, FTDP-17 and Pick's disease
9. A polymorphism in the tau gene associated with risk for Alzheimer's disease
10. Inheritance of frontotemporal dementia
11. Pathogenic implications of mutations in the tau gene in pallido-ponto-nigral degeneration and related neurodegenerative disorders linked to chromosome 17
12. Genetic evidence for the involvement of τ in progressive supranuclear palsy
13. Vulnerable neuronal subsets in Alzheimer's and Pick's disease are distinguished by their tau isoform distribution and phosphorylation
14. Segregation of a missense mutation in the microtubule-associated protein tau gene with familial frontotemporal dementia and parkinsonism
15. Identification of a novel polymorphism in the promoter region of the tau gene highly associated to progressive supranuclear palsy in humans
16. Frontotemporal dementia and parkinsonism linked to chromosome 17: A consensus conference
17. Mapping of a disease locus for familial rapidly progressive frontotemporal dementia to chromosome 17q12-21
18. Construction of a detailed physical and transcript map of the FTDP-17 candidate region on chromosome 17q21
19. The apolipoprotein E epsilon4 allele is not a significant risk factor for frontotemporal dementia
20. Tau gene mutation in familial progressive subcortical gliosis
21. Increased tau in the cerebrospinal fluid of patients with frontotemporal dementia and Alzheimer's disease
22. Abnormal phosphorylation of the microtubule-associated protein tau in Alzheimer cytoskeletal pathology
23. Frontal lobe degeneration of non-Alzheimer type II: Clinical picture and differential diagnosis
24. Clinical picture of frontal lobe degeneration of non-Alzheimer type
25. Apolipoprotein E genotyping in Alzheimer's disease and frontotemporal dementia
26. Progressive supranuclear gaze palsy is in linkage disequilibrium with the tau and not the alpha-synuclein gene
27. Frequency of tau mutations in three series of non-Alzheimer's degenerative dementia
28. Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17
29. Phosphorylated tau in human cerebrospinal fluid is a diagnostic marker for Alzheimer's disease
30. Apolipoprotein E4 accelerates dementia and increases cerebrospinal fluid tau levels in Alzheimer's disease
31. Tau gene polymorphisms and apolipoprotein E ε4 may interact to increase risk for Alzheimer's disease
32. Tau protein in cerebrospinal fluid: A new diagnostic and prognostic marker in Alzheimer disease?
33. The apolipoprotein E epsilon4 allele frequency is normal in fronto-temporal dementia, but correlates with age at onset of disease
34. Increased CSF tau protein in corticobasal degeneration
35. Frontotemporal lobar degeneration: A consensus on clinical diagnostic criteria
36. Dementia of frontal lobe type
37. Apolipoprotein E e4 allele has no affect on age of onset or duration of disease in cases of frontotemporal dementia with pick- or microvacuolar-type histology
38. Tau is a candidate gene for chromosome 17 frontotemporal dementia
39. High prevalence of mutations in the microtubule-associated protein tau in a population study of frontotemporal dementia in the Netherlands
40. Frontotemporal dementia and parkinsonism linked to chromosome 17: A new group of taupathies
41. Mutation in the tau gene in familial multiple system tauopathy with presenile dementia
42. Familial aggregation in frontotemporal dementia
43. Apolipoprotein E and Alzheimer disease
44. CSF tau is related to apolipoprotein E genotype in early Alzheimer's disease
45. A comparison of tau protein in cerebrospinal fluid between corticobasal degeneration and progressive supranuclear palsy